More about

Opioid Use Disorder

News
February 04, 2020
2 min read
Save

Depression, anxiety increased opioid use, health care costs after hip arthroscopy

Depression, anxiety increased opioid use, health care costs after hip arthroscopy

Patients with both femoroacetabular impingement and depression or anxiety had significantly greater opioid use and health care costs before and after hip arthroscopy than those who had femoroacetabular impingement alone, according to published results.

News
January 03, 2020
4 min read
Save

Prediction model shows potential for identifying cancer survivors at risk for opioid misuse

Prediction model shows potential for identifying cancer survivors at risk for opioid misuse

A novel predictive model appeared to identify cancer survivors at increased risk for opioid misuse, according to study results published in Journal of the National Cancer Institute.

News
December 31, 2019
2 min read
Save

Cause-specific opioid mortality research reveals need for combination interventions

Cause-specific opioid mortality research reveals need for combination interventions

Individuals who use illicitly manufactured opioids or pharmaceutical opioids outside the bounds of a medical prescription experience significant yet preventable excess mortality, according to results of a systematic review and meta-analysis published in JAMA Psychiatry.

News
December 26, 2019
2 min read
Save

Mind-body therapies linked to improved pain, lower opioid dose

Mind-body therapies linked to improved pain, lower opioid dose

Mind-body therapies — including meditation, cognitive behavioral therapy and hypnosis — were associated with improvements in pain and reduced opioid doses, according to a study published in JAMA Internal Medicine.

News
December 20, 2019
1 min read
Save

Congress includes mental illness, substance use disorders funding in 2020 spending bill

Congress passed a $1.4 trillion spending bill this week for fiscal year 2020 with provisions that will fund treatment programs and medical research for people with substance use disorders and mental illnesses.

News
December 19, 2019
3 min read
Save

Suicides account for 4% of opioid-related overdose deaths, much lower than previously thought

Suicides account for 4% of opioid-related overdose deaths, much lower than previously thought

Researchers have estimated that only 4% of opioid-related overdose deaths are due to suicide, which contradicts recent estimates that classified 20% to 30% as such, according to findings of a research letter published in JAMA.

News
December 09, 2019
2 min read
Save

Risk-tolerant patients with opioid use disorder more likely to relapse

Risk-tolerant patients with opioid use disorder more likely to relapse

Computational markers have revealed that patients in treatment for opioid addiction are more likely to relapse when they develop greater tolerance to risks, according to results published in JAMA Psychiatry.

News
December 05, 2019
6 min read
Save

Ibogaine treatment for opioid use disorder: What you need to know

Ibogaine treatment for opioid use disorder: What you need to know

Miami is one of the few places in the United States where researchers study ibogaine, an indole alkaloid found in the root bark of a West African shrub that has hallucinogenic properties.

News
November 06, 2019
3 min read
Save

Opioid overdose, vaccine preventable diseases among avoidable SLE-related conditions

Opioid overdose, vaccine preventable diseases among avoidable SLE-related conditions

Opioid use and overdose, and certain vaccine-preventable diseases, are among conditions related to systemic lupus erythematosus that could be avoided or minimized through high-quality, timely ambulatory care, according to findings published in Arthritis Care & Research.

News
October 30, 2019
3 min read
Save

Money from opioid lawsuit settlements ‘will never be enough’ to manage crisis

Money from opioid lawsuit settlements ‘will never be enough’ to manage crisis

Recently, two Ohio counties settled with opioid distributors AmerisourceBergen, Cardinal Health and McKesson for $215 million in cash just hours before going to trial. A fourth defendant, Teva, agreed to pay $20 million and provide $25 million worth of the opioid substitution therapy buprenorphine, according to the Los Angeles Times. Lawyers and doctors who are following the lawsuit said the settlements will fall well short of resolving the opioid epidemic.

View more